SUPG-032

N/A

Report date: 2025/05/14 14:16:41

Base Information

Drug NameSUPG-032
Drug Alias NameLEX-032
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLeukocyte elastase inhibitorsCathepsin G inhibitorsSerine protease inhibitors
TargetsLeukocyte elastaseCathepsin GSerine protease
Therapy Area/IndicationsInflammationReperfusion InjuryStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationReperfusion InjuryStroke

Other Information

ATC CodeN/A
Related LinksN/A